Skip to main content

Advertisement

SpringerLink
Log in

False-reactive hepatitis B surface antigen test results in cancer patients

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Costa V, Zhao Z, Racine-Brzostek SE, Lalazar G, Yang HS (2021) An interesting case of isolated false-reactive hepatitis B surface antigen. Case Rep Hepatol 2021:9928098

    Google Scholar 

  2. Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS (2019) Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 71(2):397–408

    Article  Google Scholar 

  3. Tang DM, Heller T, Koh C (2016) The many faces of positive hepatitis B surface antigen. Hepatology 64(4):1379–1381

    Article  Google Scholar 

  4. Delgado-García G, Mandujano-Cruz I, González-Padilla K, Alarcón-Galván G, Villarreal-Alarcón MÁ, Galarza-Delgado DÁ (2017) Isolated HBsAg positivity in a Mexican patient with newly diagnosed lupus nephritis. Egypt Rheumatol 39(1):49–52

    Article  Google Scholar 

  5. Yshii LM, Hohlfeld R, Liblau RS (2017) Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat Rev Neurol 13(12):755–763

    Article  CAS  Google Scholar 

  6. Warren K, Eastlund T (2002) False-reactive test for hepatitis B surface antigen following administration of granulocyte-colony-stimulating factor. Vox Sang 83(3):247–249

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Stephanie Deming, scientific editor, Research Medical Library, for editing this article.

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Joseph T. Klingen, Khalis Mustafayev, Marcel Yibirin & Harrys A. Torres

  2. Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jessica P. Hwang

  3. Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Harrys A. Torres

Authors
  1. Joseph T. Klingen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khalis Mustafayev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcel Yibirin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jessica P. Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harrys A. Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harrys A. Torres.

Ethics declarations

Conflict of interest

Dr. Torres is or has been the principal investigator for research grants from the National Cancer Institute, Gilead Sciences, and Merck & Co., Inc., with all funds paid to MD Anderson Cancer Center. Dr. Torres is or has been a paid scientific advisor for AbbVie, Inc., Gilead Sciences, Merck & Co., Inc., and Dynavax Technologies; MD Anderson Cancer Center is managing the terms of these arrangements in accordance with its conflict-of-interest policies. All other co-authors have no conflict of interest to report.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klingen, J.T., Mustafayev, K., Yibirin, M. et al. False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis 42, 383–385 (2023). https://doi.org/10.1007/s10096-023-04554-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04554-4

Search

Navigation